重编程M13菌体的基因组,以实现全在一体的个性化癌症疫苗
bioRxiv : the preprint server for biology
|November 28, 2024
概括
这项研究引入了一个可编程的M13菌体 (菌体) 纳米疫苗,用于个性化癌症治疗. 这种新的平台增强了免疫反应,有效地根除了瘤,为癌症治疗提供了一种有前途的新方法.
科学领域:
- 纳米技术纳米技术
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 类疫苗在免疫性和稳定性方面存在局限性.
- 基于病毒的纳米粒子,如M13菌体,在抗原呈现和辅助性方面具有优势.
- 抗原和辅助剂的有效同时递送仍然是疫苗开发中的一个挑战.
研究的目的:
- 开发一种可编程的M13菌根纳米疫苗,用于个性化癌症治疗.
- 为了实现抗原和辅助剂的单步组装.
- 通过调节菌体辅助性和抗原密度来精确控制免疫反应.
主要方法:
- 设计了一个具有可编程基因组序列的重编程 (RP) 菌体平台.
- 转基因菌体调节抗原密度.
- 在疫苗接种研究中评估了免疫反应和瘤根除.
主要成果:
- 该RP菌体平台精确调节了Toll类受体9的激活.
- 疫苗接种研究表明,通过调整辅助性和抗原密度,可以调整免疫反应.
- 当与抗PD-1疗法结合时,RP菌体疫苗接种导致新抗原特异性CD8+T细胞增加了24倍,并根除了已建立的MC-38瘤.
结论:
- RP菌体平台是一种强大的纳米疫苗,用于个性化癌症疫苗.
- 优化抗原剂量和辅助性对于最大限度的疫苗疗效至关重要.
- 这种方法显示了改善癌症免疫治疗结果的巨大潜力.
相关概念视频
Cancer Vaccines
340
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
340
Conservative Site-specific Recombination and Phase Variation
5.9K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
5.9K
Microorganisms in Medicine and Therapeutics
1
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1
CRISPR and crRNAs
16.7K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
16.7K
Lytic Cycle of Bacteriophages
70.3K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
70.3K


